Australia should not try to win the AI arms race but instead leverage its critical minerals and renewable energy while ensuring global tech giants pay fair tax, argues AirTree co-founder Daniel Petre.…
Anthropic has opened applications for a grant program under its AI for Science initiative, offering up to $50,000 in Claude API credits to researchers working on rare genetic diseases. The program, an…
Bora Pharmaceuticals and Insilico Medicine announced a strategic alliance valued at more than $2.5 billion if fully implemented, combining Insilico's Pharma.AI platform for drug discovery with Bora's …
Insilico Medicine's AI-discovered lung fibrosis drug, Rentosertib, has entered Phase III clinical trials for idiopathic pulmonary fibrosis, marking a rare late-stage test for AI drug discovery. The co…
The US government ordered Anthropic to suspend its Claude Fable 5 and Mythos 5 models due to jailbreak vulnerabilities reported by Amazon, then allowed their swift restoration after fixes. This interv…
MindWalk Holdings, trading as HYFT on NASDAQ, filed a European patent for its high-dimensional biological data architecture, signaling a strategic pivot as AI models become commoditized. The patent ap…
Astromech, a startup founded in 2025 by Ben Lamm and George Church, develops a Large Life Model and autonomous biological intelligence system that fuses evolutionary logic with deep learning to decode…
SK Biopharmaceuticals CEO Lee Dong-hoon announced the company is doubling down on AI and open innovation as core growth pillars, following a partnership with Insilico Medicine for AI-driven drug disco…
Insilico Medicine and SK Biopharmaceuticals announced a partnership valued at over $2.5 billion to use AI for developing neuroimmune therapies. Insilico will leverage its Pharma.AI platform for drug d…
Perceptic, a startup founded by three former Palantir executives, emerged from stealth today with $12 million in seed funding to build an end-to-end AI platform for drug development that handles every…